Brief: Novavax - FDA Approves Transfer Of Nuvaxovid Authorization To Sanofi - SEC Filing
Nov 4 (Reuters) - Novavax Inc NVAX.O: NOVAVAX INC - FDA APPROVES TRANSFER OF NUVAXOVID AUTHORIZATION TO SANOFI - SEC FILING NOVAVAX INC - NUVAXOVID MARKETING AUTHORIZATION TRANSFER TRIGGERS $25 MILLION PAYMENT FROM SANOFI TO NOVAVAX - SEC FILING NOVAVAX INC: ANTICIPATES RECEIPT OF MILESTONE PAYMENT FROM SANOFI IN Q1 OF 2026 Source text: [ID:n0001104659-25-105818] Further company coverage: NVAX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Novavax
See all newsNovavax shareholder Shah Capital to step back from activist role
Brief: Mabion Signs Deal With Novavax Expanding Cooperation To Analytical Services For Early-Stage Pipeline Projects
Brief: Sanofi Spokesperson Says Nuvaxovid to Be Available Across U.S. for 2026-27 Respiratory Virus Season
US FDA approves updated COVID vaccines for 2026-27 season
US STOCKS-Wall St rises as yields ease, Moderna lifts healthcare stocks